Company Encyclopedia
View More
name
IVD MEDICAL
01931.HK
IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, immunology, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the clinical laboratories of hospitals; and maintenance and repair, installation, and end customer training services.
180.82 B
01931.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care DistributorsIndustry
Industry Ranking6/21
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE5.08%C
    • Profit Margin5.66%C
    • Gross Margin22.02%D
  • Growth ScoreC
    • Revenue YoY0.61%C
    • Net Profit YoY-32.99%D
    • Total Assets YoY17.75%A
    • Net Assets YoY4.45%C
  • Cash ScoreB
    • Cash Flow Margin1766.73%B
    • OCF YoY0.61%C
  • Operating ScoreC
    • Turnover0.54C
  • Debt ScoreC
    • Gearing Ratio42.78%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Health Canada grants IVD approval to Devyser’s NGS-based chimerism test, the first of its kind in Canada

    Health Canada has approved Devyser's NGS-based chimerism test as Class III IVD medical devices, marking the first such approval in Canada. This sets a new standard for post-transplant monitoring, enabling accurate DNA quantification post-HSCT. The approval reflects Devyser's commitment to high-quality molecular diagnostics, benefiting Canadian labs with streamlined processes and rapid turnaround.

    Modular Finance Ab·
    HK
    01931
    -0.88%
    Modular Finance Ab·
    HK
    01931
    -0.88%

    Hong Kong Stock Movement: IVD MEDICAL falls 15.01%, subsidiary's reduction in holdings triggers market confidence crisis

    IVD MEDICAL fell 15.01%; Sinopharm Group rose 1.50%, with a transaction volume of HKD 36.23 million; Yaoshi Bang fell 1.85%, with a transaction volume of HKD 23.59 million; Baiyunshan fell 0.27%, with a transaction volume of HKD 20.8 million; Shanghai Pharmaceuticals rose 0.17%, with a market value of HKD 43.8 billion

    HK Stock Movers Tracker·
    HK
    01931
    -0.88%
    HK Stock Movers Tracker·
    HK
    01931
    -0.88%

    Hong Kong Stock Movement Update: BIOSINO BIO-TEC leads the rise, IVD MEDICAL falls 15%, communication stocks are active

    Hong Kong stock market overview in the past hour shows a clear divergence between the pharmaceutical and technology sectors. The performance of the pharmaceutical sector is mixed, with BIOSINO BIO-TEC leading the gains at 15.89%, while IVD MEDICAL is under pressure, falling by 15.01%. The technology sector, on the other hand, is favored by funds, with ZTE rising by 10.31%, indicating a preference for tech stocks. The overall market rhythm is fast-paced, with noticeable short-term enthusiasm and rapid switching of funds between different sectors. In the past hour, the most notable stock movement is BIOSINO BIO-TEC, which has seen a remarkable increase of 15.89%. Funds seem to have a strong appetite for it, driving the stock price upward continuously. The activity in the pharmaceutical sector has also increased, attracting more short-term funds' attention. Strong stocks: 1. BIOSINO BIO-TEC: Up 15.89%, with significant fund inflow, and the market is full of expectations for its future performance. 2. ZTE: Up 10.31%, the leader of the technology sector, with continuous fund inflow, showing market confidence in tech stocks. Stocks under pressure: 1. IVD MEDICAL: Down 15.01%, a weak representative of the pharmaceutical sector, with significant fund outflow, and market sentiment is cautious

    HK Stock Movers Tracker·
    HK
    08247
    +3.77%
    HK
    01931
    -0.88%
    HK
    00763
    -1.04%
    HK Stock Movers Tracker·
    HK
    08247
    +3.77%
    HK
    01931
    -0.88%
    HK
    00763
    -1.04%

    IVD Medical Holding Files Next Day Disclosure Return to HKEX After Repurchasing 1,187,000 Shares for HKD 7.72 Million

    IVD Medical Holding Ltd. filed a disclosure return with HKEX after repurchasing 1,187,000 shares for HKD 7.72 million, to be held as treasury shares.

    Reuters·
    HK
    01931
    -0.88%
    Reuters·
    HK
    01931
    -0.88%

    IVD Medical Holding Repurchases 15.33 Million Shares for HK$230,140 in HKEX Disclosure

    IVD Medical Holding Ltd. repurchased 15.33 million shares for HK$230,140, as disclosed in a filing with the Hong Kong Stock Exchange. This action was under its authorized mandate. The information was published via the Issuer Information Service of HKEX on November 27, 2025. The news brief was generated by Public Technologies using AI.

    Reuters·
    HK
    01931
    -0.88%
    Reuters·
    HK
    01931
    -0.88%
    Posts
    View More
    © 2025 Longbridge｜Disclaimer